10Feb 2018

PROGNOSTIC VALUE OF THE EXPRESSION OF ENDOGENOUS HYPOXIA ASSOCIATED PROTEINS HYPOXIA INDUCIBLE FACTOR-1 ALPHA (HIF-1) AND CARBONIC ANHYDRASE ISOFORM 9 (CAIX) EXPRESSIONS IN BREAST CARCINOMA.

  • Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
  • Department of Pathology, Faculty of Medicine, Benghazi University, Benghazi, Libya.
  • Department of Clinical Oncology and nuclear medicine, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
  • Department of General surgery, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: hypoxia has been found to be related to malignant initiation, progression, increasing the occurrence of metastasis and therapy resistance in many cancer types, which made a real need for discovering drugs that could antagonize the bad effect of hypoxia in cancer, decide which patients will have benefit from such anti-hypoxia therapy then to monitor response to therapy, especially in breast carcinoma. It is important to detect degree of hypoxia in each cancer that could be done by evaluation of the expression of hypoxia-associated proteins in cancer biopsies e.g. hypoxia inducible factor-1 alpha (HIF-1?) and carbonic anhydrase IX (CAIX) and their detailed role in breast cancer is still uncertain and gives conflicting results. Aim of the work: was to evaluate HIF-1? and CAIX expressions in breast carcinoma, correlating their expressions with each other, with presence of lymph node & distant metastases, with recurrence free and overall survival rates of female patients with breast cancer. Methods: we evaluated HIF-1? & CAIX expressions in sections from 90 paraffin blocks of breast carcinoma using immunohistochemistry. We analyzed correlations between their levels of expressions, clinic-pathological and prognostic parameters of our patients. Results: HIF-1? and CAIX positive expression in breast carcinoma was related to advanced stage, presence of lymph node metastases, HER2 amplified and triple negative molecular subtypes (p<0.001), higher tumor grade (p= 0.001& 0.02 respectively) and negative ER (p= 0.005& 0.008 respectively) & PR (p= 0.009& 0.027 respectively) hormonal receptors, The expression of both markers was significantly positively correlated with each other (p<0.001). HIF-1? and CAIX positive expression in breast carcinoma was associated with shortened recurrence free and overall survival rates (p<0.001). Conclusion: HIF-1? and CAIX are markers of poor prognosis of breast carcinoma patients.

  1. Aomatsu N, Yashiro M, Kashiwagi S, Kawajiri H, Takashima T, Ohsawa M, et al. Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline. BMC Cancer. 2014; 14:400.
  2. Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Ryden L, Gallagher WM, O\'Brien SL. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006;12:6421?6431
  3. Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol. 2003; 67:3?15. [PubMed: 12758235].
  4. Ward, S. P. Langdon, P. Mullen et al., ?New strategies for targeting the hypoxic tumour microenvironment in breast cancer,? Cancer Treatment Reviews, 2013; 39:171?179.
  5. -L. Chen, J.-S. Chu, W.-C. Su, S.-C. Huang, and W.-Y. Lee, ?Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX,? Virchows Archiv, 2010; 457: 53?61,.
  6. Sch?utze, K. Milde-Langosch, I. Witzel et al., ?Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer,? Journal of Cancer Research and Clinical Oncology, 2013; 139: 747?754,.
  7. Y. Tan, M. Yan, L. Campo et al., ?The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy,? British Journal of Cancer, 2009;100:405?411,.
  8. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002; 19:403?410.
  9. E. Lock, P. C. McDonald, Y. Lou et al., ?Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche,? Oncogene, 2013;32: 5210?5219,.
  10. Giuliano AE1, Connolly JL2, Edge SB3, Mittendorf EA4, Rugo HS5, Solin LJ6, et al., Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393.
  11. Glaberman UB, Marron M, Chalasani P, Livingston R, Iannone M, Specht J et al., Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer Disease Markers Volume 2016, Article ID 9810383, 7 pages http://dx.doi.org/10.1155/2016/9810383
  12. Hsu SM, Raine L and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981; 29:577-580.
  13. Jiang BH, Semenza GL, Bauer C, Marti HH Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol (1996) ; 271: C1172?C1180
  14. Keun-Yong Eom, Min Hye Jang, So Yeon Park, Eun Young Kang, Sung Won Kim, Jee Hyun Kim, Jae-Sung Kim, In Ah Kim, The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer Cancer Res Treat. 2016;48(1):125-132.
  15. Kronblad A, Jirstrom K, Ryden L, Nordenskjold B, Landberg G. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Int J Cancer. 2006; 118(10):2609?2616. Epub 2005/12/29. doi: 10.1002/ijc.21676 PMID: 16381002
  16. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH and Van de Vijver MJ, eds. WHO Clas?sification of Tumours of the Breast. Fourth ed. IARC, Lyon; 2012. ISBN.13.
  17. Lee WY, Huang SC, Hsu KF, Tzeng CC, Shen WL . Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol Oncol 2008; 108:377?384
  18. Liu Z-j Semenza GL, Zhang H-f. Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ Sci B. 2015; 16(1):32?43. doi: 10.1631/jzus.B1400221 PMID: PMC4288942
  19. Nalwoga H, Ahmed L, Arnes JB, Wabinga H, Akslen LA. Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer PLOS ONE | DOI:10.1371/journal.pone.0146823 January 13, 2016
  20. Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P et al., PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 2014; 211: 781?790.
  21. C. McDonald, J.-Y. Winum, C. T. Supuran, and S. Dedhar, ?Recent developments in targeting carbonic anhydrase IX for cancer therapeutics,? Oncotarget, , 2012; 3: 84?97.
  22. Rafajova M, Zatovicova M, Kettmann R, Pastorek J, Pastorekova S Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol 2004;24: 995?1004.
  23. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010; 29:625?634. [PubMed: 19946328]
  24. Semenza, G. L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33, 207?214.
  25. Sobhanifar S, Aquino-Parsons C, Stanbridge EJ, Olive P. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. Cancer Res 2005; 65:7259?7266
  26. Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013; 20:2213-8.
  27. Sun JD, Liu Q, Wang J, et al. Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. Clin Cancer Res. 2012; 18:758?770. [PubMed: 22184053]
  28. Supuran CT. Development of small molecule carbonic anhydrase IX inhibitors. BJU Int. 2008;101(Suppl 4): 39?40
  29. Thiry A, Dogne JM, Masereel B, Supuran CT . Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006; 27:566?
  30. Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyssegur J, Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 2007; 120:1451?1458.
  31. M?uller, S. Riethdorf, B. Rack et al., ?Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IXin correlation to circulating tumor cells in patients with metastatic breast cancer,? Breast Cancer Research, vol. 13,no. 4, article R71, 2011.
  32. Wigerup C, P?hlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer Pharmacology & Therapeutics 2016; 152?169.
  33. Wojtkowiak JW, Cornnell HC, Matsumoto S, et al. Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302. Cancer Metabol. 2015; 3:2.
  34. Wong, C.C.L., Zhang, H., Gilkes, D.M., et al., Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. Mol.Med., 2012; 90(7):803-815. [doi:10.1007/s00109-011-0855-y]
  35. Lou, P. C. McDonald, A. Oloumi et al., ?Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors,? Cancer Research, 2011;71: 3364?3376,
  36. Zatovicova M, Jelenska L, Hulikova A, et al. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des. 2010; 16:3255?3263. [PubMed: 20819068].
  37. Zhang W, Shi X, Peng Y, Wu M, Zhang P, Xie R, et al. HIF-1alpha Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. PLoS One. 2015; 10(6):e0129603. doi: 10.1371/journal.pone.0129603 PMID: 26057751
  38. Zhang, H.,Wong, C. C.,Wei, H., Gilkes, D.M., Korangath, P., Chaturvedi, P et al., HIF-1-dependent expression of angiopoietin-like 4 and L1CAMmediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 2012; 31:1757?1770.

[Ola A. Harb, Ibtesam Elhasadi, Amal M A Adim, Warda M Said, Sharifa A. M. El.Ammari, Basant Sh El Shafaay Fady M. Habib and Loay M. Gertallah. (2018); PROGNOSTIC VALUE OF THE EXPRESSION OF ENDOGENOUS HYPOXIA ASSOCIATED PROTEINS HYPOXIA INDUCIBLE FACTOR-1 ALPHA (HIF-1) AND CARBONIC ANHYDRASE ISOFORM 9 (CAIX) EXPRESSIONS IN BREAST CARCINOMA. Int. J. of Adv. Res. 6 (Feb). 950-969] (ISSN 2320-5407). www.journalijar.com

Ola A. Harb
Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt,

DOI:

Article DOI: 10.21474/IJAR01/6516      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6516

Download Full Paper

Download PDF No. of Downloads: 7 | No. of Views: 66